We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer. Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.
Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its...
Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its...
Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.015 | 1.86067827681 | 54.55 | 59.72 | 54.2 | 764526 | 56.70733982 | CS |
4 | 9.435 | 20.4530674182 | 46.13 | 71.71 | 40.0183 | 1750609 | 59.70373427 | CS |
12 | 12.195 | 28.1185151026 | 43.37 | 71.71 | 40.0183 | 992328 | 55.62027153 | CS |
26 | 14.375 | 34.8992473901 | 41.19 | 71.71 | 34.5125 | 759068 | 50.89103543 | CS |
52 | 44.975 | 424.693106704 | 10.59 | 71.71 | 7.79 | 767433 | 48.14090043 | CS |
156 | 33.535 | 152.224239673 | 22.03 | 71.71 | 5.65 | 319571 | 41.18849137 | CS |
260 | 21.565 | 63.4264705882 | 34 | 71.71 | 5.65 | 300211 | 39.62917678 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions